Chandra Bhagat Pharma Ltd IPO (CBC Pharma IPO) Detail

Jan 31, 2020 - Feb 6, 2020

Incorporated in 2003, Chandra Bhagat Pharma Limited is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. They provide pharmaceuticals and special chemical products in the Indian and international market.

The company has own sales force and distribution network to work under the brand name and supply products to the Health care center and Hospital. Chandra Bhagat Pharma also deals in import, supply and indenting in Active Pharmaceuticals Ingredients (API) and the intermediate.

The company has FDA approval to get formulations manufactured from a contract manufacturer. It has a presence for formulations in some therapeutic categories such as Anesthesia, Cardiovascular, Anti-cancer (Oncology), Pediatrics, Nephrology, Antiviral, Anti-fungal, and Neurology. The warehouses/ storage houses of the company are on lease agreements at Bhiwandi- Thane, Maharashtra.

Chandra Bhagat Pharma also exports Pharmaceutical Formulations to other countries like DR Congo, Bolivia and Philippines.

Competitive Strengths

1. Customer centric and order driven business model
2. Relationships with MNCs
3. Wide product portfolio including API and pharmaceuticals
4. Contract manufacturing facility
5. Presence in India and international market

Company Financials

Summary of financial Information (Restated)
Particulars For the year/period ended (Rs in Lakhs)
30-July-19 31-Mar-19 31-Mar-18 31-Mar-17
Total Assets 8,594.26 8,285.52 5,805.76 5,589.60
Total Revenue 3,344.50 10,671.83 9,773.41 9,028.11
Profit After Tax 24.88 62.59 103.38 66.03

Objects of the Issue

The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:

1. To Meet Incremental Working Capital Requirements;
2. Setting up Distribution and Warehousing Centre's;
3. General Corporate Purpose;
4. To meet Public Issue Expenses

CBC Pharma IPO Details

CBC Pharma IPO Date Jan 31, 2020 to Feb 6, 2020
CBC Pharma IPO Face Value ₹10 per share
CBC Pharma IPO Price ₹51 per share
CBC Pharma IPO Lot Size 2000 Shares
Issue Size2,000,000 shares of ₹10
(aggregating up to ₹10.20 Cr)
Issue Type Fixed Price Issue IPO
Listing At BSE SME
P/E (x)51
Market Cap (₹ Cr.)38.48
Company Promoters

Mr. Hemant Chandravadan Bhagat and Mr. Pranav Hemant Bhagat are the promoters of the company.

CBC Pharma IPO Timeline (Tentative Timetable)

CBC Pharma IPO opens on Jan 31, 2020, and closes on Feb 6, 2020. The CBC Pharma IPO bid date is from Jan 31, 2020 10.00 A.M. to Feb 6, 2020 5.00 P.M. The Cut-off time for UPI Mandate confirmation is 5 PM on the issue closing day.

Event Date
CBC Pharma IPO Opening Date Jan 31, 2020
CBC Pharma IPO Closing Date Feb 6, 2020
Basis of Allotment Feb 11, 2020
Initiation of Refunds Feb 13, 2020
Credit of Shares to Demat Feb 13, 2020
CBC Pharma IPO Listing Date Feb 14, 2020

CBC Pharma IPO Lot Size

The CBC Pharma IPO lot size is 2000 shares. A retail-individual investor can apply for up to 1 lots (2000 shares or ₹102,000).

Application Lots Shares Amount
Retail (Min) 1 2000 ₹102,000
Retail (Max) 1 2000 ₹102,000

CBC Pharma IPO Promoter Holding

Pre Issue Share Holding 96.72%
Post Issue Share Holding 71.08%

CBC Pharma IPO Review

CBPL has shown inconsistency in bottom lines despite growing top lines. With the vaccine product launch plans up the sleeve, it is poised for bright prospects as claimed by the management. However, all these positive factors are discounted in the asking price. Hence only cash surplus, risk savvy investors may consider investment for long term at their own risk. Read detail review...

CBC Pharma IPO Subscription Status (Bidding Detail)

The CBC Pharma IPO is subscribed 1.65 times on Feb 6, 2020 6:45:03 PM. The public issue subscribed 1.44 times in the retail category, times in the QIB category, and 1.87 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)

CBC Pharma IPO Prospectus

CBC Pharma IPO Rating

Rating:Rated 3.5 stars
Vote Here ...

CBC Pharma IPO Listing Date

Listing Date Friday, February 14, 2020
BSE Script Code 542934
NSE Symbol
Listing In MT Group of Securities
IPO Price ₹51 per share
Face Value ₹10 per share

Listing Day Trading Information

IPO Price
Last Trade

Company Contact Information

Chandra Bhagat Pharma Ltd
323-F Bhagat Bhuvan,
Dr. Ambedkar Road,
Matunga (East) Mumbai- 400019
Phone: +91 22 2414 6154

CBC Pharma IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270

CBC Pharma IPO Review

CBC Pharma IPO Recommendation Summary

Review By Subscribe Neutral Avoid
Brokers 1 0 0
Members 0 0 0

Read All Reviews Post Your Review Manage Reviews

IPO Broker Recommendations


CBC Pharma IPO is a SME IPO of 2,000,000 equity shares of the face value of ₹10 aggregating up to ₹10.20 Crores. The issue is priced at ₹51 per share. The minimum order quantity is 2000 Shares.

The IPO opens on Jan 31, 2020, and closes on Feb 6, 2020.

Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE SME.

The CBC Pharma IPO opens on Jan 31, 2020 and closes on Feb 6, 2020.

CBC Pharma IPO lot size is 2000 Shares and the minimum order quantity is .

You can apply in CBC Pharma IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for CBC Pharma IPO will be done on Feb 11, 2020, and the allotted shares will be credited to your demat account by Feb 13, 2020. Check the CBC Pharma IPO allotment status.

The CBC Pharma IPO listing date is on Friday, February 14, 2020.
Open an Instant Account with Zerodha

CBC Pharma IPO Message Board

Ranked Members of Forum  Ranked Members | Most Liked Members



23. RAJAKUMAR |   Link |Feb 17, 2020 9:49:00 AM
IPO Guru IPO Guru (1400+ Posts, 1200+ Likes)
Dear Small
Sold 4 lot at 51.8
one lot holding, Now placed order at 51
22. Small Investor |   Link |Feb 14, 2020 2:26:37 PM
IPO Guru IPO Guru (1600+ Posts, 900+ Likes)
Selling pressure now active , exit if any hold
21. Small Investor |   Link |Feb 14, 2020 10:11:03 AM
IPO Guru IPO Guru (1600+ Posts, 900+ Likes)
Dear Raja
You Sold your 5 lot or Hold , Listing bellow Expected
20. Dinesh Singh |   Link |Feb 14, 2020 9:56:05 AM
IPO Guru IPO Guru (1000+ Posts, 400+ Likes)
Sold @ 52.10 one lot.
20.1. Small Investor |   Link |Feb 14, 2020 10:08:14 AM
IPO Guru IPO Guru (1600+ Posts, 900+ Likes)
SOLD @ 52
19. Johny |   Link |Feb 14, 2020 4:51:43 AM
IPO Mentor IPO Mentor (700+ Posts, 900+ Likes)
All the best to all for a good listing!
18. RAJAKUMAR |   Link |Feb 13, 2020 12:08:14 PM
IPO Guru IPO Guru (1400+ Posts, 1200+ Likes)
Dear Small
I got 5/8
17. RAJAKUMAR |   Link |Feb 13, 2020 12:07:35 PM
IPO Guru IPO Guru (1400+ Posts, 1200+ Likes)
Dear Small
Rs 1.5 to 2.5 listing premium possible.
16. BLR |   Link |Feb 13, 2020 7:55:50 AM
0/2 ( No allotment )
15. Dinesh Singh |   Link |Feb 12, 2020 9:56:20 AM
IPO Guru IPO Guru (1000+ Posts, 400+ Likes)
Allotted 1 lot. Amount debited from bank.
15.2. Small Investor |   Link |Feb 12, 2020 4:34:10 PM
IPO Guru IPO Guru (1600+ Posts, 900+ Likes)
Listing May be On 13th Feb ?,In Last FPO and Janu Corp also List before tentative date
So Keep Touch Top IPO Site

Name of the company Chandra Bhagat Pharma Limited
Scrip Code : 542934
Symbol :CBPL
ISIN No:.INE07QQ01016

Listing Possible Tomorrow ?

15.3. Dinesh Singh |   Link |Feb 12, 2020 8:59:58 PM
IPO Guru IPO Guru (1000+ Posts, 400+ Likes)
Listing is on 14th...
Confirm by chittorgarh.
14. Johny |   Link |Feb 12, 2020 10:33:28 AM
IPO Mentor IPO Mentor (700+ Posts, 900+ Likes) link to check allotment
13. Hiteshji |   Link |Feb 11, 2020 3:59:24 PM
IPO Mentor IPO Mentor (500+ Posts, 400+ Likes)
Tomorrow allotment..
13.1. Splendid |   Link |Feb 11, 2020 4:38:14 PM
Top Contributor Top Contributor (200+ Posts, 100+ Likes)
I got amount deduction message from Bank. So allotment done.
12. IPO FEVER |   Link |Feb 9, 2020 11:33:04 AM
Cbc pharma grey Mkt premium 2/- Buyer
12.2. IPO FEVER |   Link |Feb 10, 2020 6:02:15 PM
12.3. traderji |   Link |Feb 10, 2020 6:45:36 PM
how / from where we got this premium details.
11. Dinesh Singh |   Link |Feb 6, 2020 11:38:59 AM
IPO Guru IPO Guru (1000+ Posts, 400+ Likes)
Please don't apply in this.
HNI will not go above 3 times.
11.2. Dinesh Singh |   Link |Feb 6, 2020 12:30:14 PM
IPO Guru IPO Guru (1000+ Posts, 400+ Likes)
Don't go by track record. See the subscription and then apply.
11.3. Small Investor |   Link |Feb 6, 2020 1:34:22 PM
IPO Guru IPO Guru (1600+ Posts, 900+ Likes)
I take risk and applied in CBC also for 1 lot
10. Sayan |   Link |Feb 6, 2020 1:02:02 PM
We should not compare a 10cr IPO with a 4cr IPO. 1.5times NII subscription in 10cr IPO is more than 3times NII in 4cr IPO. and there is LM with good track record who can play vital role on listing day.
9. K joshi |   Link |Feb 4, 2020 7:17:10 PM
NII show good response and may give good return in long term
9.1. Darsh ipo |   Link |Feb 5, 2020 11:08:46 PM
Listing game milna chahiye....sme bahut kam log long term hold karte hain...
8. Dinesh Singh |   Link |Feb 4, 2020 7:49:35 PM
IPO Guru IPO Guru (1000+ Posts, 400+ Likes)
Please don't apply unless HNI subscribes more than 3 times.
8.1. K joshi |   Link |Feb 5, 2020 1:13:48 PM
Hni is oversubscribed 3 times
8.2. K joshi |   Link |Feb 5, 2020 1:15:55 PM
Sorry it is 1.50 times and not 3
Type mistake
7. K joshi |   Link |Feb 5, 2020 10:33:29 AM
Transway techno gave 10 % listing gain for small investors and SME will give normally same return.
CBC may do well as rightly NII have good response.
6. RAJAKUMAR |   Link |Jan 30, 2020 11:20:50 PM
IPO Guru IPO Guru (1400+ Posts, 1200+ Likes)
Dear Small
Eps for 2019 Mar is 1.17 pe is 43
Eps 0.46 as on July 19 and pe 110
RONW IS 4.71 as March 19 and July 1.84 (after issuing bonus shares at 7:1)
Nav as on July 19 is 25 against issue price of 51
Peer group Earum Pharma trading at 0.84 pe and Vishali Pharma 24 pe trading much lower than Candra is coming at pe of 110 (As on July 19)
Shareholder Fund is 14 Cr. (July 19)
Long term Debt is 9 Cr. and short term debt is 17Cr.
Debt is two times more than shareholder fund which is quite high.
Debt/Equity Ratio is 2.05 and it will reduce to 1.25 after issue. DRHP 168
Litigation by company is 2 (DRHP 168)
Litigation against company is 4 (involves 2 Dishonour cheque involves 27 lakh and 2.4 lakh
other 2 cases involves 11 lakh and 38 lakh.
Pending Litigation (drhp 170)
4 out of 3 is against Govt. of India. Other litigation (DRHP 170 TO 179)
Dear Small
Lot of litigation against company but amount involves is not much.
Drhp 170 to 179 no time to read other litigation
LM is Beeline so i will apply. Because so for three issues handled and all listing positive.
Since Sme stock dont look financial and other things, we need listing gain only.
That may happen i think so.
I will take risk and apply 2 application.

6.1. K joshi |   Link |Feb 4, 2020 7:11:33 PM
Very true
When beeline sure investors will earn
5. K joshi |   Link |Feb 4, 2020 7:10:25 PM
NII is giving good response. CBC has done awareness for IPO and market become good today. Long term good
4. Small Investor |   Link |Jan 31, 2020 1:19:08 PM
IPO Guru IPO Guru (1600+ Posts, 900+ Likes)
NII is rocking Now
4.2. Small Investor |   Link |Feb 3, 2020 4:59:35 PM
IPO Guru IPO Guru (1600+ Posts, 900+ Likes)
4.3. K joshi |   Link |Feb 4, 2020 9:21:38 AM
May be NII have long term strategy as HepA product will hv big demand and improve profit